Session Details
[2YIA18m]YIA Pharmacology Group 2
Tue. Mar 18, 2025 8:30 AM - 10:20 AM JST
Tue. Mar 18, 2025 11:30 PM - 1:20 AM UTC
Tue. Mar 18, 2025 11:30 PM - 1:20 AM UTC
Room 18
Oranizers : Takahiko Shiina (Laboratory of Pathophysiology, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University) and Isao Naguro (Faculty of Pharmacy, Juntendo University )
[2YIA18m-1]TP signaling in macrophages facilitates liver repair after APAP-induced liver injury through the promotion of M2 polarization and hepatocyte growth factor production
○Mina Tanabe1, Yoshiya Ito1,2, Seishirou Akinaga1, Takuya Yamazaki1, Yu Kuroda1, Atsushi Yamashita1, Mariko Kamata2, Kanako Hosono2, Ko Hatanaka2, Masataka Majima3, Hideki Amano1,2 (1.Department of Molecular pharmacology, Graduate School of Medical Sciences, Kitasato University, 2.Department of Pharmacology, Kitasato University School of Medicine, 3.Department of Medical Therapeutics, Kanagawa Institute of Technology)
[2YIA18m-2]Multi-Omics approach to identifying sex differences in cisplatin excretion mechanisms in the proximal tubules of the kidney.
○Satoshi Shimizu1,2, Kongpracha Pornparn2, Aoi Mizuno1, Masaki Miyasaka2, Wiriyasermkul Pattama2, Masami Kodama1, Kazuho Sakamoto1, Yuji Nakai3, Shushi Nagamori2, Junko Kurokawa1 (1.Dept. Bio-inform. Pharmacol., Sch. Pharmaceut. Sci., Univ. Shizuoka, 2.Center Med. Res., The Jikei Univ. Sch. Med, 3.Sect. Food Sci., Inst. Reg. Innov., Hirosaki Univ.)
[2YIA18m-3]Elucidation of the mechanism of Ca2+-sensitization in rat caudal arterial smooth muscle stimulated with high K+
○Kazuki Aida1, Yu Miyamoto1, Kaito Yoshida2, Tomiyuki Sugi2, Reiko Ishii-Nozawa1 (1.Department of Pharmacology, Meiji Pharmaceutical University, 2.Department of Practical Pharmacy, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University)
[2YIA18m-4]Inhibitors and knockdown of PRMT5 suppress the differentiation from lung fibroblasts into myofibroblasts
○Chiharu Hirai1, Yasufumi Katanasaka1,2,3, Natsumi Hagawa1, Ryuya Naruta1,2,3, Yuto Kawase1, Yoichi Sunagawa1,2,3, Toshihide Hamabe1, Koji Hasegawa1,2, Tatsuya Morimoto1,2,3 (1.Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan,, 2.Division of Translational Research, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho Fukakusa, Fushimi-ku, Kyoto, 612-8555, Japan, 3.Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, 420-8527, Japan)
[2YIA18m-5]The role of κ opioid receptors in regulation of energy homeostasis
○Naomi Yonemochi1, Hiroshi Nagase2, Hiroko Ikeda1 (1.Hoshi Univ., 2.Univ. Tsukuba)
[2YIA18m-6]Zerumbone, a component of the herb Zingiber zerumbet Smith, ameliorates kidney fibrosis
○Ryuya Naruta1, Yasufumi Katanasaka1,2,3, Yuto Kawase1, Yoichi Sunagawa1,2,3, Toshihide Hamabe-Horiike1,2,3, Koji Hasegawa2, Tatsuya Morimoto1,2,3 (1.Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, 2.Division of Translational Research, Kyoto Medical Center,, 3.Shizuoka General Hospital)
[2YIA18m-7]Investigation of microRNA (miRNA) that regulate blood pressure in extracellular vesicles (EV) derived from plasma of spontaneously hypertensive rats (SHR)
○Yusei Fujioka, Yui Miyashita, Haruki Takeuchi, Kosuke Otani, Muneyoshi Okada, Hideyuki Yamawaki (Lab. Vet Pharmacol., Sch. Vet Med., Kitasato Univ.)
[2YIA18m-8]HMG-CoA reductase inhibitors alleviate different types of chemotherapy induced-peripheral neuropathy via activation of GST
○Fuka Aizawa1,2, Ami Okabayashi2, Takahiro Niimura2,3, Karin Takeuchi2, Kenta Yagi2,3, Yoshito Zamami4, Mitsuhiro Goda1,2, Kei Kawada2,5, Yuki Izawa-Ishizawa2,6, Keisuke Ishizawa1,2,3 (1.Dept. Pharm., Tokushima Univ. Hosp., 2.Dept. Clin. Pharmacol. & Therap., Grad. Sch. of Biomed. Sci., Tokushima Univ., 3.Clin. Res. Ctr. Dev. Therap., Tokushima Univ. Hosp., 4.Dept. Pharm., Okayama Univ. Hosp., 5.Dept. Pharm. Pract. Pedagog., Tokushima Univ., 6.Dept. Gen. Med., Taoka Hosp.)
[2YIA18m-9]Canine Lung Cancer Organoids as a Comparative Oncology Model for Translational Research in Therapeutic Development
○Yomogi Shiota1,2, Haru Yamamoto3, Kiyoshi Minakami3, Tatsuya Usui4 (1.Tokyo University of Agriculture and Technology, Institute of Global Innovation Research, 2.National Cancer Center Research Institute, Division of Rare Cancer Research, 3.Tokyo University of Agriculture and Technology, Veterinary Pharmacology Laboratory, 4.Tokyo University of Agriculture and Technology, Institue of Agriculture Science)